Circulatory shock.
Patients with malignancy may present with acute circulatory compromise requiring ICU monitoring and care. The clinician must be familiar with a multiplicity of acute and chronic medical conditions common to the general population and also with conditions directly related to cancer or therapy thereof.
Bogolioubov
A
A
Division of Critical Care Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.
Keefe
D L
DL
Groeger
J S
JS
D000307:Adrenal Gland Diseases / Q000150:complications; D000310:Adrenal Gland Neoplasms / Q000150:complications / Q000601:surgery; D018943:Anthracyclines / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D002276:Carcinoid Tumor / Q000209:etiology / Q000628:therapy; D002305:Cardiac Tamponade / Q000209:etiology; D009202:Cardiomyopathies / Q000209:etiology; D005472:Fluorouracil / Q000009:adverse effects; D006331:Heart Diseases / Q000209:etiology* / Q000503:physiopathology; D006333:Heart Failure / Q000139:chemically induced; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D010673:Pheochromocytoma / Q000150:complications / Q000601:surgery; D012769:Shock / Q000209:etiology / Q000503:physiopathology; D012772:Shock, Septic / Q000150:complications / Q000503:physiopathology
D018943:Anthracyclines; D000970:Antineoplastic Agents; D005472:Fluorouracil